Correlation between Classic Driver Oncogene Mutations in EGFR , ALK , or ROS1 and 22C3–PD-L1 ≥50% Expression in Lung Adenocarcinoma

出版年份 2017 全文链接

标题

作者

关键词

Lung cancer, PD-L1, PD-1, Pembrolizumab, EGFR, ALK

出版物

Volume 12, Issue 5, Pages 878-883

出版商

Elsevier BV

发表日期

2017-01-17

DOI

10.1016/j.jtho.2016.12.026

联系作者

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started